Search results for

Climate change is raising the risk of dangerous flooding, especially in coastal communities. For some towns on the Jersey Shore, the most practical solution is raising homes off the ground.

The CEO of Facebook testified before Congress for the first time on Tuesday. He apologized for allowing Facebook tools to be used to do harm — and vowed to take more responsibility over user content.

International pressure is building on Iran. On Wednesday, Iranian leaders claimed they made strides in their nuclear program and threatened to stop supplying oil to six European countries. Host Michel Martin hears what people inside the country think about the tensions. She speaks with writer Hooman Majd and human rights activist Sussan Tahmasebi.

Interest rates on mortgages are at an all-time low. But refinancing can be a daunting process. Financial guru and author Louis Barajas speaks with guest host Viviana Hurtado about the ins and outs of refinancing, and what consumers can do to make the process go more smoothly.

Elon Musk is buying Twitter for $44 billion. An effective COVID drug will be made available to more pharmacies. Ex-President Trump is held in contempt of court for failing to turn over documents.

The FAA has grounded all Boeing 737 Max aircraft in the U.S. as investigators probe the cause of the crash in Ethiopia. Also, new information suggests the special counsel's investigation is done.

The White House wants to fight climate change in ways that also remove economic and racial disparities. The city of Cleveland has a plan that describes what that might mean.

In the first of our six-part series, NPR's Bob Mondello explains how the theater that most Americans see is being transformed.

The FDA will vote on whether to clear Pfizer's COVID-19 vaccine for emergency use. Two lawsuits question how Facebook got so big. Plus, lawmakers on Capitol Hill debate a COVID-19 relief package.

U.S. officials say Iran is behind threatening election emails to voters. The final Trump-Biden presidential debate is hours away. And, Purdue Pharma reaches a deal with DOJ over OxyContin sales.